KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

Merck (MRK) Shares Issued (2016 - 2026)

Merck has reported Shares Issued over the past 18 years, most recently at $157.0 million for Q1 2026.

Quarterly Shares Issued rose 726.32% to $157.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $230.0 million through Mar 2026, up 111.01% year-over-year, with the annual reading at $92.0 million for FY2025, 48.02% down from the prior year.
Shares Issued was $157.0 million for Q1 2026 at Merck, up from $47.0 million in the prior quarter.
Over five years, Shares Issued peaked at $265.0 million in Q4 2022 and troughed at $5.0 million in Q3 2024.
The 5-year median for Shares Issued is $19.0 million (2025), against an average of $55.0 million.
Year-over-year, Shares Issued plummeted 97.74% in 2023 and then skyrocketed 726.32% in 2026.
A 5-year view of Shares Issued shows it stood at $265.0 million in 2022, then plummeted by 97.74% to $6.0 million in 2023, then skyrocketed by 100.0% to $12.0 million in 2024, then soared by 291.67% to $47.0 million in 2025, then skyrocketed by 234.04% to $157.0 million in 2026.
Per Business Quant, the three most recent readings for MRK's Shares Issued are $157.0 million (Q1 2026), $47.0 million (Q4 2025), and $14.0 million (Q3 2025).